Importance & Scope:
Europeans are plagued by cancer, with almost 2.8 million people or 38 percent of the population suffering each year, Cancer and illnesses cause a huge economic and social burden measured in the hundreds of billions of Euros.
In Spain, there are approximately 0.8 million new cases of cancer each year. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.
Lung cancer is one of the most aggressive tumours and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.
Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.
Prostate cancer, today the most common tumour in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.
Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.
The CONFERENCE on cancer therapy is intended to provide a medium for the communication of results and ideas in the field of cancer science. The CONFERENCE welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for cultural topics related to the cancer science
Valencia is much spurred by tourism. Many local landmarks were restored, including the ancient Towers of the medieval city (Serrano Towers and Quart Towers), and the San Miguel de los Reyes monastery which now holds a conservation library. The city has numerous convention centres and venues for trade events, among them the Feria Valencia Convention and Exhibition Centre (Institución Ferial de Valencia) and the Palau de congres (Conference Palace), and several 5-star hotels to accommodate business travellers.
Valencia is one of Spain’s largest cities, and is having 3 societies & 100+ oncologist and 114 Hospitals with cancer treatment.
- Cancer –Basic and Applied Research
- Organ-Specific, Cancer Genetics
- Advances in Cancer treatment and Biomarkers
- Anti cancer drug delivery
- Novel Approaches to Cancer Therapeutics and metabolomics
- Advancement in Cancer Therapy
- Cancer immunobiology, immunotherapy and Stem Cell Therapy
Why to attend???
Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants.. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.
A Unique Opportunity for Advertisers and Sponsors at this International event:
Major Cancer Associations around the Globe
American Society of clinical oncology (ASCO)
International Agency for Research on Cancer (IARC)
American Association for Cancer Research (AACR)
International Cancer Research Partnership (ICRP)
National Cancer Institute (NIC)
Major Cancer Associations in Europe
European Society of Medical Research (ESMR)
Statistical Analysis of Associations
Figure 1: Statistical Analysis
Researchers, Academicians, Physicians , Post Docs, Students ,Pharma Industries, Academic scientists ,Industry professionals ,Diagnostic laboratory professionals.
Researchers - 30%
Industry Professionals- 15%
Figure 2: Target Audience
Top Universities in Spain:
Catalan Institute of Oncology Barcelona, Spain
Fundacion Instituto Valenciano de Oncologia (IVO), Valencia Spain
Instituto Madrileño de Oncología, FondacionGrupo (IMO), Madrid Spain
Figure 3: Top Universities in Spain
Companies Associated with Advertising and Marketing activities
Figure 4: Companies associated with cancer
Hospitals Associated with Cancer
Figure 5: Hospitals Associated with cancer
Statistics of members associated with cancer research
Figure 5: Members Associated with cancer